GDNF预处理递载丛蛋白Plexin B2细胞外囊泡在缺血性脑卒中神经损伤中的机制研究
批准号:
82104147
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
王广天
依托单位:
学科分类:
神经精神药物药理
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
王广天
中文摘要
随着医疗条件的进步,卒中患者的死亡率逐渐降低,但幸存患者的预后较差。脑缺血后神经元损伤的程度是决定预后的主要因素。因此,需要进一步阐明拯救受损神经元的调控机制,以寻求有效降低神经元损伤的治疗方案。申请人预实验发现,脑缺血周围区皮层中Plexin B2表达下调,Plexin B2下调显著加重脑梗死体积,Plexin B2主要表达在神经元细胞中。构建靶向中枢的GDNF预处理递载Plexin B2细胞外囊泡(GDNF-Plexin B2-EVs)确认其能靶向到脑部及促进脑卒中后功能恢复。基于此,申请人提出“GDNF预处理递载丛蛋白Plexin B2细胞外囊泡促进缺血性脑卒中后的神经损伤修复”这一科学假设。本项目将从动物、细胞和分子水平,深入探讨GDNF-Plexin B2-Evs对缺血性脑卒中后神经损伤修复的作用,明确Plexin B2在神经元凋亡中的分子机制,为促进脑卒中神经损伤修复提供靶标。
英文摘要
With the advancement of medical conditions, the mortality of stroke patients has gradually decreased, but the prognosis of surviving patients is poor. The degree of neuronal damage after cerebral ischemia is the main factor determining the prognosis. Therefore, it is necessary to further clarify the regulatory mechanism of saving damaged neurons to seek effective treatments. The applicants previous studies found that the expression of Plexin B2 in the peri-infarct cortex was down-regulated, and the down-regulation of Plexin B2 significantly increased cerebral infarction volume. Moreover, the Plexin B2 was mainly expressed in neurons. Based on previous studies, the applicant constructed GDNF-pretreated Plexin B2 extracellular vesicles (GDNF-Plexin B2-EVs) and confirmed that these EVs could target the brain and promote functional recovery after stroke. Based on these findings, the applicant proposed the scientific hypothesis of “ The GDNF-pretreated extracellular vesicles containing Plexin B2 promte nerve injury after ischemic stroke”. This project aims to explore the effect of GDNF-Plexin B2-EVs on the repair of nerve damage after ischemic stroke from the animal, cell and molecular level, clarify the role and molecular mechanism of Plexin B2 in neuronal apoptosis and provide a target for promoting the repair of nerve injury in stroke.
脑卒中是一种常见的中枢神经系统疾病,可分为缺血性脑卒中和出血性脑卒中,缺血性脑卒中约占全球所有脑卒中总数的87%。脑卒中已成为全球范围内成年人致残的主要原因,给人类社会带来巨大的健康问题和经济负担。随着医疗条件的进步,目前卒中患者的死亡率逐渐降低,但是幸存患者的预后并没有得到显著改善。脑缺血后神经元损伤的程度是决定预后的主要因素。因此,挽救受损神经元是改善脑卒中患者预后的有效策略。我们研究发现Plexin B2主要存在于神经元。tMCAO建立的小鼠脑卒中模型中脑内Plexin B2表达异常,过表达Plexin B2可以有效改善缺血性脑卒中症状,减小死体积,证实PlexinB2参与脑缺血损伤后神经保护及相关的机制研究。同时,过表达Plexin B2神经干细胞中的细胞外囊泡能够增加其释放,这一发现将为脑卒中后脑损伤的治疗提供理论依据和潜在药物靶点。
国内基金
海外基金